MAIA · ISSUER CIK 1878313
MAIA Biotechnology, Inc.
Between Jul 31, 2026 and Oct 28, 2026, 2 MAIA Biotechnology, Inc. insiders reported $352K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Guerrero Ramiro (Director), with $252K.
↗2 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. No open-market sales in the window.
$352KInsider buying
$0.00Insider selling
+$352KNet open-market
Sep 15, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 202606:33 | Sep 14, 2026 | MAIA | Chief Executive Officer, Director, 10% Owner | P · Buy | $1.37 | +73,000 | 1,049,121 | +7% | +$100K | -7.4% | -15.3% |
| Sep 14, 202609:03 | Sep 10, 2026 | MAIA | Director | P · Buy | $1.32 | +37,595 | 773,296 | +5% | +$50K | -11.0% | -11.9% |
| Sep 1, 202616:16 | Aug 28, 2026from Aug 26, 2026 | MAIA | Director | P · Buy | $1.38 | +133,790 | 735,701 | +22% | +$184K | -8.3% | -15.7% |
| Aug 26, 202607:56 | Aug 24, 2026 | MAIA | Director | P · Buy | $1.33 | +1,794 | 601,911 | +0% | +$2K | -11.3% | -12.8% |
| Aug 24, 202616:09 | Aug 20, 2026 | MAIA | Director | P · Buy | $1.37 | +11,899 | 600,117 | +2% | +$16K | -8.7% | -15.3% |